Matinas BioPharma Holdings, Inc. MTNB
Set alert
1.29 USD -0.22 -14.57%
At close · Nov 2
1.27 -0.02 -1.55%
After hours · Nov 2, 6:17 PM ET
0.97 Day range 1.54
0.97 52-week range 20.85
- YTD
- +120.14%
- 1 year
- -6.52%
- Open
- 1.49
- Prev close
- 1.51
- Mkt cap
- 1.26M
- Vol
- 224.16K
- Avg vol
- 91.27K
- EPS
- -17.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.97
- High
- 1.54
- Forward P/E
- -0.17
- Beta
- 1.73
- Short ratio
- 0.19
- Inst. own
- 26.08%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.38
- 200-d avg
- 6.37
- 1y target
- 0.00
5D chart
Signals (35)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 12:20 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 11:50 AM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 10:55 AM | 14 hours ago |
| SMA: Bullish | Nov 2, 10:50 AM | 14 hours ago |
| MACD: Sell Signal | Oct 30, 3:45 PM | 3 days ago |
| RSI: Oversold | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:40 AM | 3 days ago |
| RSI: Oversold | Oct 30, 11:40 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:30 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:15 AM | 3 days ago |
| RSI: Overbought | Oct 30, 11:15 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:50 AM | 3 days ago |
Newest 20 of 35.
Financial health
Altman Z-Score
-94.31 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -0.3×
FY 2016 5y median -2.0× FY 2025
P/S 0.0×
FY 2016 5y median 34.0× FY 2025
P/B 0.7×
FY 2016 5y median 2.4× FY 2025
P/FCF -0.5×
FY 2016 5y median -3.0× FY 2025
EV/EBITDA -0.1×
FY 2016 5y median -2.1× FY 2025
EV/Sales 0.0×
FY 2016 5y median 33.1× FY 2025
FCF Yield -218.6%
FY 2016 5y median -33.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median -771.3% FY 2025
Net Margin 0.0%
FY 2016 5y median -658.6% FY 2025
ROE -214.2%
FY 2016 5y median -119.2% FY 2025
ROIC -108.1%
FY 2016 5y median -102.7% FY 2025
ROA -143.5%
FY 2016 5y median -91.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 65.5%
FY 2016 FY 2025
EPS (diluted) 59.8%
FY 2016 FY 2025
Free Cash Flow 55.9%
FY 2016 FY 2025
Financial Health
Current Ratio 2.8×
FY 2016 5y median 5.9× FY 2025
Quick Ratio 2.8×
FY 2016 5y median 5.9× FY 2025
Debt / Equity 0.3×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.3×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
